Page last updated: 2024-10-30

6-anilino-5,8-quinolinedione and Benign Neoplasms, Brain

6-anilino-5,8-quinolinedione has been researched along with Benign Neoplasms, Brain in 1 studies

6-anilino-5,8-quinolinedione: structure given in first source; SRS-A & guanylate cyclase antagonist
6-anilino-5,8-quinolinedione : A quinolone that is quinoline-5,8-dione in which the hydrogen at position 6 is replaced by an anilino group.

Research Excerpts

ExcerptRelevanceReference
"The effect of 6-anilino-5,8-quinolinedione (LY83583), an inhibitor of guanylyl cyclase (GC), on the growth of human brain tumor cells (U-373 MG astrocytoma and SK-N-MC neuroblastoma) was evaluated."3.69Mechanism of potentiation of LY83583-induced growth inhibition by sodium nitroprusside in human brain tumor cells. ( Lee, YS; Wurster, RD, 1995)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lee, YS1
Wurster, RD1

Other Studies

1 other study available for 6-anilino-5,8-quinolinedione and Benign Neoplasms, Brain

ArticleYear
Mechanism of potentiation of LY83583-induced growth inhibition by sodium nitroprusside in human brain tumor cells.
    Cancer chemotherapy and pharmacology, 1995, Volume: 36, Issue:4

    Topics: Aminoquinolines; Analysis of Variance; Antineoplastic Agents; Astrocytoma; Brain Neoplasms; Calcium;

1995